Control Of Muscle Mass During Growth And Aging: Clinical Targets And Pathways
Our muscles are vital for much more than just movement; they play a crucial role in our overall health, metabolism, and even how well we age. Throughout our lives, our bodies are constantly working to maintain a healthy amount of muscle through a delicate balance. On one side, we have “anabolic pathways,” which are like the construction crews building and repairing muscle tissue. A key player here is the mTOR pathway (mammalian target of rapamycin), a cellular signaling system that helps regulate cell growth and protein production. On the other side are “catabolic pathways,” which are responsible for breaking down muscle, for example, the myostatin signaling pathway.
As we get older, this finely tuned balance often shifts. Our bodies can become less efficient at building new muscle, a phenomenon known as “anabolic resistance”. This can be due to various factors, including changes in hormones, how our bodies respond to insulin, and issues with our cells’ energy factories, called mitochondria. This age-related decline in muscle mass, strength, and function is a condition known as sarcopenia. It can significantly impact quality of life, increasing the risk of falls and limiting independence.
Understanding these intricate cellular processes is crucial for developing effective strategies to combat muscle loss. Research highlights that a comprehensive approach is most effective. This includes regular physical activity, especially resistance exercises, along with carefully planned nutrition. In the future, targeted medications might also play a role in helping us maintain strong, healthy muscles as we age, ultimately improving our functional capacity and overall well-being.
Source: link to paper